Items tagged with Advocacy

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment (post with simple image)

120,707 people signed petitions urging the corporation to drop the price.

Treatment Action Group statement on bedaquiline unaffordability (post with simple image)

Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.

TB CAB Statement (post with simple image)

TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction

Activating a human rights-based TB response (post with simple image)

A technical brief for policymakers and program implementers - a joint effort of the Global Coalition of TB Activists, the Stop TB Partnership and the Northwestern Pritzker School of Law.

TAG launches two new TB Activist Guides (post with simple image)

Treatment Action Group launches two new TB Activist Guides: An Activist’s Guide to Tuberculosis Diagnostic Tools, and An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis.

Letter to Sanofi calling for patent withdrawals on critical TB drugs (post with simple image)

TAG and OTMeds call on Sanofi to reverse its efforts to patent two obvious combinations of two critical drugs to prevent TB: rifapentine and isoniazid.

Declaration of the Rights of People Affected by TB now available in Arabic (post with simple image)

The Declaration was launched in May 2019 by TBpeople in partnership with the Stop TB Partnership.

TAG policy brief: TB Research Investments Provide Returns in Combating Both TB and COVID-19 (post with simple image)

Sustained and expanded financing is needed to safeguard TB research against COVID-19–related disruptions and improve global epidemic preparedness.

TAG policy brief: Advancing Access through Market Interventions (post with simple image)

Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down

Public investment in bedaquiline up to five-fold that of Johnson & Johnson (post with simple image)

PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.

Page 97 of 105 · Total posts: 0

←First 96 97 98 Last→